Fatty acid transport proteins in disease: new insights from invertebrate models Pierre Dourlen, Alyson Sujkowski, Robert Wessells, Bertrand Mollereau PII: DOI: Reference:
S0163-7827(15)30006-0 doi: 10.1016/j.plipres.2015.08.001 JPLR 885
To appear in: Received date: Accepted date:
27 July 2015 18 August 2015
Please cite this article as: Dourlen Pierre, Sujkowski Alyson, Wessells Robert, Mollereau Bertrand, Fatty acid transport proteins in disease: new insights from invertebrate models, (2015), doi: 10.1016/j.plipres.2015.08.001
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT Fatty acid transport proteins in disease: new insights from invertebrate models
PT
Pierre Dourlen1, Alyson Sujkowski2, Robert Wessells2, Bertrand Mollereau1
RI
1) Laboratory of Molecular Biology of the Cell, UMR5239 CNRS/Ecole Normale Supérieure de Lyon, UMS 3444 Biosciences Lyon Gerland, Université de Lyon, Lyon, France
NU
SC
2) Department of Physiology, Wayne State University School of Medecine, Detroit, MI, USA
AC CE P
TE
D
MA
Corresponding authors:
[email protected] and
[email protected]
1
ACCEPTED MANUSCRIPT Abstract The dysregulation of lipid metabolism has been implicated in various diseases, including diabetes, cardiopathies, dermopathies, retinal and neurodegenerative diseases. Mouse
PT
models have provided insights into lipid metabolism. However, progress in the understanding
RI
of these pathologies is hampered by the multiplicity of essential cellular processes and genes that modulate lipid metabolism. Drosophila and C. elegans have emerged as simple genetic
SC
models to improve our understanding of these metabolic diseases. Recent studies have
NU
characterized fatty acid transport protein (fatp) mutants in Drosophila and C. elegans, establishing new models of cardiomyopathy, retinal degeneration, fat storage disease and
MA
dermopathies. These models have generated novel insights into the physiological role of the Fatp protein family in vivo in multicellular organisms, and are likely to contribute substantially to progress in understanding the etiology of various metabolic disorders. Here, we describe
TE
D
and discuss the mechanisms underlying invertebrate fatp mutant models in the light of the
AC CE P
current knowledge relating to FATPs and lipid disorders in vertebrates.
2
ACCEPTED MANUSCRIPT Box1: Gene and protein nomenclature fatp, Drosophila gene Fatp, Drosophila protein
PT
Fatp1, mammalian gene
RI
FATP1, mammalian protein
SC
FATP and FATP, the general family of genes and proteins without consideration of species
NU
Box2: List of abbreviations: ACS: acyl-CoA synthetase
MA
ACSVL: very long-chain acyl-CoA synthetase AMD: age-related macular degeneration AMPK: AMP-activated protein kinase
CoA: Coenzyme A
TE
D
AMP, ATP: adenosine mono-phosphate, adenosine tri-phosphate
AC CE P
DGAT2: diacylglycerol acyltransferase-2 DILPs: Drosophila insulin-like peptides ER: endoplasmic reticulum FA: fatty acid
LCFA: long-chain fatty acid
VLCFA: very long-chain fatty acid FABPpm: plasma membrane FA-binding protein FACS: FA-coA synthase FAT: fatty acid translocase FATP: fatty acid transport protein HFD: high-fat diet IPS: Ichthyosis Prematurity Syndrome LD: lipid droplet LRAT: lecithin retinol acetyl transferase
3
ACCEPTED MANUSCRIPT N-ret-PE: N-retinylidene-phosphatidylethanolamine PDH: pigment-cell-enriched dehydrogenase PG: pheromone gland
PT
PR: photoreceptor neuron
RI
RDH: retinol dehydrogenase Rh1: Rhodopsin1
SC
RPE: Retinal pigment epithelium
NU
SLC27: solute carrier family 27 SNP: single nucleotide polymorphism
AC CE P
TE
D
MA
TAG: triacylglycerol – triglycerides
4
ACCEPTED MANUSCRIPT Introduction
Fatty acids (FA) and in particular long chain FA (LCFA) are major sources of energy in the
PT
cell. FA are transported into cells and activated by linking to a Coenzyme A (CoA) to
RI
generate FA-CoA, a necessary intermediate for FA elongation, triacylglycerol / triglyceride (TAG) synthesis and FA β-oxidation. Dysregulation of FA transport and activation can
SC
provoke a dysregulation of lipid homeostasis, which plays a major role in many medical
NU
conditions, including obesity, diabetes, cardiopathies, skin syndromes and several diseases of the central nervous system, including diseases of the retina [1–3].
MA
Key actors of FA transport and activation are the FATP family of proteins officially named solute carrier family 27 (SLC27), herein referred to as FATP for simplicity [4,5]. The
D
mammalian FATP family includes six members that have distinct expression patterns. They
TE
exhibit varying degrees of specialization in FA transport or activation, and are associated with lipid disorders in humans. For example, several single nucleotide polymorphisms
AC CE P
(SNPs) within Fatp1 are associated with increased plasma triglyceride levels [6,7]. A polymorphism in the Fatp4 gene is associated with insulin resistance [8]. Missense and nonsense mutations in Fatp4 have been identified in patients with ichthyosis prematurity syndrome (IPS) [9,10]. Finally, a polymorphism in Fatp5 is associated with hepatic injury, insulin resistance, and dyslipidemia [11]. The variety of FATP mutations that are associated with lipid disorders suggests that FATP proteins could be useful therapeutic targets to maintain lipid homeostasis. Our understanding of the pathological mechanisms associated with disruption of lipid homeostasis is hampered by gene redundancy between FATP family members and by redundancy with other FA transport proteins, such as the plasma membrane fatty acid translocase (FAT/CD36) and the plasma membrane fatty acid binding protein (FABPpm), as well as Acyl-CoA synthetase (ACS). In addition, due to the variety of mechanisms controlled by lipids, which include cell signaling, membrane composition and energy production, it is often difficult to pinpoint the causes and consequences of the deregulations [12].
5
ACCEPTED MANUSCRIPT A way to address this issue is to investigate the fundamental mechanisms in simpler genetic model organisms in which pathways can be more clearly defined. For example, the molecular activity of FATPs has been successfully examined in the genetically tractable
PT
yeast model, Saccharomyces cerevisiae, as described below. For physiological studies in
RI
multicellular organisms, the classical genetic models are the fruit fly Drosophila melanogaster and the nematode Caenorhabditis elegans.
SC
For many years, Drosophila and C. elegans were not considered to be suitable models for
NU
the study of lipid metabolism, because they provide little material for biochemistry compared with rodent models (Table 1). However, recent advances in high mass resolution shotgun
MA
lipidomics have made detailed lipidomic analyses possible for small organisms [13–15]. For example, it is now possible to quantify 250 lipid species from 14 major classes with only ½ of a gut or 5 brains from third instar Drosophila larvae [15]. Consequently, research in lipid
TE
D
metabolism can now benefit from the unquestioned genetic power of these model organisms. Not only the ease of knocking down or overexpressing any genes anywhere at any time, but
AC CE P
the low gene redundancy in these organisms, allow the rapid dissection of key enzymatic steps [16]. With the emergence of these models for studying dysfunctions of lipid metabolism [1,17,18], significant improvements in our understanding of the role of lipid metabolism in living animals have been made possible. Here, in addition to vertebrate FATPs, we review recent analyses of fatp mutations in Drosophila and C.elegans and their use for the establishment of genetic models of lipid disorder-associated diseases, especially cardiac, retinal, and fat storage diseases, as well as dermopathies.
The FATP family throughout evolution. The FATP family is conserved from yeast to human, with one gene in S.cerevisiae (FAT1), two genes in C.elegans (acs-20 and acs-22), three genes in D.melanogaster (fatp, CG30194 and CG3394) and six genes in mammals (Fatp1 to Fatp6). In phylogenetic analyses, worm and fly genes cluster with vertebrate Fatp1 and Fatp4, whereas Fatp2, Fatp3, Fatp5 and Fatp6 constitute a group only present in vertebrates [19]. Fatp1 and Fatp4 are likely to have
6
ACCEPTED MANUSCRIPT the evolutionarily conserved functions of the family, and therefore studies of their orthologs in worms and flies are informative. In vertebrates and invertebrates, the expression of FATP family members is tissue specific
PT
(Table 2). In mammals, each FATP family member has a defined expression profile and
RI
functions in specific tissues with differences among species [4,20,21] . Some Fatp genes, such as Fatp1 and Fatp4, are expressed in multiple, overlapping tissues and organs. In the
SC
mouse, Fatp1 and Fatp4 are both expressed in the adipose, colon, heart, kidney, liver, lung,
NU
ovary, small intestine, testis and placenta, with higher levels of Fatp1 in the adipose and higher levels of Fatp4 in the small intestine [20]. In contrast, other Fatp genes have a more
MA
restricted profile and are only found in a few dedicated organs. For example, in the mouse, Fatp2 is mainly expressed in the liver, kidney and small intestine while Fatp5 is mainly expressed in the liver [20].
D
In invertebrates, FATP expression is also tissue-specific (http://www.flyatlas.org/ and
TE
http://www.wormbase.org/, Table2). In adult Drosophila, fatp is thought to be the major
AC CE P
member of the family as it is very strongly expressed in the adult eye, hindgut, fat body, heart and carcass, whereas fatp paralogs, CG3394 and CG30194, are only moderately expressed in some of the tissues of the adult fly (Table 2). These latter are more expressed in the larval stage.
Molecular activity of FATP proteins FATP proteins are characterized by two subdomains, the ATP-AMP motif, common to all members of the adenylate-forming superfamily of enzymes, and the FATP-ACSVL motif, restricted to the FATP family [22]. The first member of the FATP family was named Fatty acid transport protein 1 (FATP1) due to its ability to increase the uptake of fluorescent FA by 3T3L1 adipocytes [23]. It fulfilled the criteria of a fatty acid transporter, as expression and localization to the plasma membrane of adipocytes caused specific and saturable uptake of LCFAs [23]. Sequence analysis of FATP1 also revealed motifs in common with ACSs,
7
ACCEPTED MANUSCRIPT including the ATP-AMP forming motif. Accordingly, it was shown that FATP1 displays verylong-chain acyl-CoA synthetase (ACSVL) activity in cell culture [24]. These results raised controversies concerning the true nature of FATP proteins and their
PT
molecular activities: are they ACSs, FA transporters or both? In addition, is the ACS activity
RI
involved in FA import or independent? This issue was strongly debated for FATP4 in particular, due to a disagreement on whether it localized to the plasma membrane, as
SC
required for a membrane FA transporter, or instead in intracellular organelle membranes
NU
[25–28]. Studies using the yeast FATP ortholog gene, FAT1, which encodes Fat1p, have helped to clarify the issues. Using several assays, it has been shown that Fat1p is a
MA
bifunctional protein performing both FA transport and activation (Fig. 1), although with different FA specificities. Deletion of FAT1 impairs uptake of LCFA and impairs growth under conditions where yeast are auxotrophic for LCFA [29]. By contrast, activation of VLCFA in
TE
D
FAT1∆ strain is reduced by 70% without affecting LCFA activation [30–32]. Furthermore, specific amino acid substitutions can eliminate one of these activities while leaving the other
AC CE P
intact, indicating that transport and activation functions of Fat1p are completely separable in yeast cells [33]. However, Fat1p does also contribute to the activation of LCFA by forming a physical complex with the fatty acyl-CoA synthetases (FACS), Faa1p and Faa4p, to perform FA import by vectorial acylation [34]. This process consists in the coupling of exogenous FA transport through the plasma membrane with the activation of the FA by esterification with a CoA [22,35]. Thus, import of LCFA is coupled to esterification, but not by the ACS activity of Fat1p itself. The yeast model system has also been used to dissect the properties of mammalian FATPs. All six murine FATP isoforms have been expressed and their activities compared in a yeast strain (fat1∆ faa1∆) deficient for both transport of LCFA and activation of VLCFA [36]. This model provides a well-defined heterologous system to distinguish transport and activation functions. In this model, all FATP isoforms except FATP5 exhibit ACSVL activities, while only FATP1, -2, and -4 restore LCFA transport function [36]. The ACS activity of FATP1, 2, 3 and 6 each appears to be specific of VLCFA substrates, while FATP4 can also target LCFA [36].
8
ACCEPTED MANUSCRIPT A naturally occurring variant of FATP2, FATP2b, has no ACSVL activity, but nevertheless enhances exogenous FA import when expressed in fat1∆ faa1∆ yeast. This is consistent with distinct transport and activation functions of FATP2 [37]. FATP5, also known as Bile acyl-coA
PT
synthetase, is the only murine protein with no ACSVL activity in yeast cells. In mammals, this
RI
protein is found in liver, where it has the unique function among FATPs of conjugating bile acid to CoA, a necessary step for recycling of secreted bile [38,39]. The inability of FATP6 to
SC
complement the transport defect of the faa1∆ fat1∆ strain is more surprising as it has been
NU
described as a heart-specific FA transport protein [40]. This may be due to an inability of the murine FATP6 to interact with endogenous yeast proteins with ACS activity, such as Faa4p.
MA
Nevertheless, the potential role of FATP6 in cardiac FA transport requires further study. Mammalian FATPs have been proposed to cooperate with additional ACS proteins for vectorial acylation of FA. This idea is supported by the fact that none of the murine FATP
TE
D
isoforms are able to complement the ACS-deficient faa1∆ faa4∆ strain [36], indicating a requirement for endogenous proteins with ACS activity. Also, in 3T3 L1 adipocytes, FATP1
AC CE P
and ACSL1 form a complex at the plasma membrane and synergistically increase LCFA uptake in fibroblasts [41,42], demonstrating a functional association in a key mammalian cell type. Of note, overexpression of Acsl1 in mouse and faa1 in yeast also increases fatty acid transport [23,36].
Plasma membrane localization of FATP1, FATP2 and FATP4 may not be required for increasing FA uptake. In this case, intracellular esterification of FA with CoA decreases the concentration of free FA within the cell and drives FA uptake by a partially undefined mechanism [26,43–45]. C. elegans and Drosophila FATP proteins exhibit clear sequence conservation with yeast Fat1p and mammalian FATPs, suggesting that they possess both ACSVL and fatty acid transport activities. The ACSVL activity has been demonstrated for the C.elegans FATP family proteins ACS-20 and ACS-22, as the incorporation of C26:0 fatty acids into sphingomyelin is reduced in acs-20;acs-22 mutant worms [46]. ACS-20 is localized at the
9
ACCEPTED MANUSCRIPT endoplasmic reticulum, and has not been detected at the plasma membrane, suggesting it may not be involved in direct transport [46]. Transport and activation functions of Drosophila Fatp have not yet been experimentally
PT
verified. However, Fatp shows a strong conservation in the AMP-ATP and FATP-ACSVL
RI
motifs, and in the residues required for LCFA transport and ACSVL activities as defined by mutagenesis in yeast (Fig. 2) [33]. Drosophila Fatp is also more similar to FATP1 and FATP4
SC
than to FATP6 (respectively 66%, 68% and 43% similarities) in an additional region of
NU
FATP1 and FATP4 that appears to be important for fatty acid transport activity when expressed in yeast (Fig. 2) [47].
MA
Transport and activation functions of insect Fatp have been verified in the pheromone gland (PG) of the silkworm Bombyx mori [48]. PGs of female moths treated with BmFATP dsRNA accumulate noticeably smaller lipid droplets (LDs) with less dietary C18:2 and C18:3 FA in
TE
D
their TAG than control. It is associated with decreased import of fluorescent FA BODIPY and reduced uptake of extracellular radiolabeled LCFAs. The mechanism of transport could be
AC CE P
similar to vectorial acylation. However, no interaction with any ACSL has been tested, although ACSL are conserved in insects. Such experiments in insects would be an opportunity to study complexes between FATPs and ACSLs in vivo in a multicellular organism. In addition, knockdown of BmFATP reduces the activation of C16:0 and C18:1 in PG homogenates [48] and the expression of Fatp from the moth Eilema japonica increases C18:0 and C20:0 uptake in Escherichia coli [49].
The role of FATP in cardiac function In vertebrates, cardiac tissue is highly dependent on FA utilization to meet the high energy needs of a continuously active tissue [50]. Therefore, cardiac function is critically dependent on the correct regulation of FA uptake and utilization. FA are thought to enter the cardiomyocyte in two forms: 1) as components of lipoproteins [51,52] and 2) as free FAs [53]. Free FA entry is partly dependent on the membrane localization and activity of FATP family proteins [40]. Studies in both intact mice and cardiac myocytes have shown that imbalances
10
ACCEPTED MANUSCRIPT in FA transport and use, due to changes in Fatp expression, lead to the progression of various cardiopathies [54–56]. The relationship between FATP levels and lipotoxic cardiomyopathy is complex, as both
PT
underexpression and overexpression have been shown to reduce cardiac function. Protein
RI
levels of FAT/CD36, the plasma membrane FA binding protein (FABPpm), FATP1 and 6, were all found to be low in a rat model of myocardial infarction, causing a shift in metabolism
SC
away from FA oxidation. In this study, the degree of myocardial dysfunction was directly
NU
proportional to the decrease in FA oxidation [57]. In a second study, FATP1 was overproduced in mouse myocardial tissue. This cardiac overproduction of FATP1 resulted in
MA
higher levels of myocardial free FA uptake, and of cardiac FA accumulation and metabolism, leading to left ventricular dysfunction [58].
Cell culture studies have implicated hormonal signaling in the regulation of FATP trafficking
TE
D
to the plasma membrane, activating FA transport into the cell. The cellular distribution of FATPs seems to be critical for the transport of FAs to various metabolic pools, for storage
AC CE P
and/or ATP production. Insulin induces the translocation of FATP1 to the plasma membrane, which is accompanied by an increase in LCFA uptake in cultured adipocytes [27]. Likewise, obesity has been observed to induce a relocalization of FABPpm and FAT/CD36 to the membranes of cardiomyocytes [59]. Interestingly, AMP-activated protein kinase (AMPK) overexpression can rescue insulin resistance in lipodystrophic cardiomyocytes, by mimicking contraction-stimulated glucose uptake without preventing lipid accumulation [60], providing a potential molecular link between exercise and the rescue of lipodystrophic cardiomyopathy. Studies of mutants in the fly model collectively suggest that the genetic regulation of cardiac development, contractility and metabolism in the fly heart is similar to vertebrates [61]. These similarities are such that the fly heart has been developed as a model for the identification of genetic factors linking high-fat or high-sugar diets to cardiac lipotoxicity in humans [62–64]. For example, flies on a high-fat diet accumulate lipid droplets in the myocardium and develop conduction blocks and cardiomyopathies. These phenotypes can be rescued by genetically reducing TOR Kinase pathway activity or by increasing expression of lipases in cardiac
11
ACCEPTED MANUSCRIPT tissue [62]. The fly heart was further used to discover that the PGC1-α homolog, spargel, is regulated by TOR Kinase and by the ATGL homolog brummer in the presence of high-fat diet, and that the deleterious effects of a high-fat diet can be rescued by overexpression of
PT
spargel [65]. When flies are fed on high-sugar, they also accumulate lipid droplets, and
RI
develop fibrosis-like phenotypes. These phenotypes could be rescued by decreasing the activity of the hexosamine biosynthetic pathway [64]. Additionally, the fly heart has been
SC
used as a model system to detail the effects of isocalorically altering nutrient composition on
NU
cardiac performance [66]. Even the effects of time-restricted feeding on physiology have been examined using the Drosophila heart as a model [67].
MA
Decreasing Drosophila fatp expression, either by genomic mutation or by heart-specific knockdown, leads to increases in myocardial lipid accumulation and autophagy that are
D
correlated with cardiac dysfunction [68]. Flies with low levels of fatp expression have a higher
TE
cardiac frequency and lower fractional shortening, and are more sensitive to pacing-induced stress. Interestingly, mice overexpressing Fatp1 in cardiac tissue also have an altered QT
AC CE P
interval, indicating a disruption of electrical activity [58]. Defects in electrical conductance have also been observed in other organs, including the retinas in mutant flies and mice [69,70].
The cardiac phenotypes of flies with low levels of fatp expression are entirely attributable to the higher levels of lipid storage in the myocardium, as treatments rescuing this lipid accumulation phenotype, either through lipase overexpression (Wessells, unpublished observation) or endurance exercise [68], also rescue cardiac function. It remains unclear whether AMPK is required for exercise to rescue lipodystrophic phenotypes in the fly model; this could be addressed in the near future by exercising AMPK knockdown flies fed a HFD. Although mice and especially rats have established, effective exercise protocols available, the advantage of the flies for exercise lies in the availability of the many genetic tools available, while flies are exercising. The heart phenotypes of fatp mutant flies could also serve as a perfect readout for modifier screens.
12
ACCEPTED MANUSCRIPT C. elegans have no heart. However, their pharynx has already been used as a heart model to study heart amyloidosis [71]. Indeed, pharynx muscle cells have autonomous contractile activity, reminiscent of cardiac myocytes. Nevertheless, the role of the C.elegans FATP
RI
PT
family proteins ACS-20 and ACS-22 have not been studied in these cells yet.
SC
The role of FATP in retina
NU
FATP and the lipid content of retina
Mammals and Drosophila eyes are composed of equivalent cell types despite a different
MA
organization. C elegans, on the other hand, does not have eyes, per se, but some lightsensitive neurons exist and are essential for negative phototaxism [72]. Contrary to the single-chambered mammalian eye, Drosophila has a faceted/compound eye composed of
TE
D
800 units called ommatidia [73]. However, mammalian retina and each Drosophila ommatidium both contain light-sensitive photoreceptor neurons (PR), mammalian rod and
AC CE P
cone PRs being functionally equivalent to the Drosophila R1-R6 outer PRs and R7-R8 inner PRs, respectively. The mammalian retina also contains epithelium cells in the retinal pigment epithelium (RPE). This epithelium makes the link between the neuroretina and blood circulation and has vital functions in nutrition, protection and maintenance of the retina [74]. The equivalent cell types in the fly retina are the interommatidial cells (IOCs). Both in mammalian and fly PRs, components of the phototransduction cascade are inserted in membranes, organized as thousands of discs in the outer segment of mammalian PR and as thousands of microvilli in the rhabdomere of fly PRs. The outer segment of mammalian PRs are phagocytosed daily by the RPE and concomitantly renewed by membrane biogenesis at their bases. Therefore these membranous structures are very dynamic. Maintenance of these structures requires high lipid transport and metabolism in the retina and a unique lipid composition of the retina. The outer segments of PR display the highest content of docosahexaenoic acid (DHA, C22:6), a polyunsaturated FA contributing to membrane fluidity, in the human body [75]. In contrast, Drosophila has very few FA longer
13
ACCEPTED MANUSCRIPT than C18. Instead, Drosophila has high levels of unsaturated C16 (C16:1) and C18 (C18:1, C18:2 and C18:3) FA. Physical properties of PR membranes are important as structural parameters, but they are also important for signaling. In Drosophila, upon light exposure, the
PT
cleavage of the minor lipid membrane phosphatidylinositol 4,5-bisphosphate (PIP2) by the
RI
NORPA phospholipase C (PLC) leads to a contraction of the rhabdomere, which is able to activate mechanosensitive channels [76]. Lipid composition of PR membrane is therefore
SC
essential to anchor and regulate the activity of proteins involved in phototransduction.
NU
In the Drosophila retina, Fatp is detected mainly in IOCs and in PRs, which could fit with a role of fatp in the supply of FA to the retina and the PRs [69]. Drosophila fatp expression
MA
begins during pupal stage, i.e. at late stage of PR differentiation, period during which PR morphogenesis takes place and at the end of which, rhodopsin (Rh), the light-sensitive protein, starts to be expressed [69,77]. fatp expression has been shown to be
D
developmentally regulated by Inositol-requiring enzyme 1 (Ire1), an essential gene of the
TE
unfolded protein response (UPR) [78]. fatp mRNA is a specific target of regulated Ire1-
AC CE P
dependent decay (RIDD). This regulation of fatp expression by ER stress and UPR pathways could be very relevant in mammals in neurological and hepatic disorders in which both dysregulation of lipid metabolism and ER stress have been observed [79,80]. In Ire1 mutant retina, Fatp levels are elevated and this is associated with higher levels of phosphatidic acid, suggesting a role of Fatp in phosphatidic acid synthesis, potentially due to an increased cellular import of FA [78]. Phosphatidic acid is involved in the regeneration cycle of PIP2, a central component of the phototransduction cascade. Interestingly, fatp-/- retina exhibits higher amplitude of the depolarization upon light stimulation [69]. This result could be explained by an impact of fatp on the PIP2 cycle. Thus, Fatp could regulate the FA composition of the retina with functional consequences. Analysis of the lipid composition of fatp-/- retina would be very informative. In mammals, two FATP members, Fatp1 and Fatp4, have been shown to be expressed in retina [70,81,82]. These two members are also the predominant Fatp members expressed in the microvessel endothelial cells of the Blood Brain Barrier where they selectively facilitate
14
ACCEPTED MANUSCRIPT the transport of long-chain fatty acids, such as oleate (C18:1) and linoleic acid (C18:2) [83,84]. Surprisingly loss of Fatp1 does not affect the composition of total FA in the retina [70]. This may be due to a redundancy with Fatp4 but the loss of Fatp1 is not associated with
PT
a compensatory increase of Fatp4. It remains possible that FA composition in the different
RI
lipid species of the Fatp1-/- retina is altered rather than the composition of total FA. Future analysis of the FA and lipid compositions of Fatp4-/- and double knock-out Fatp1-/- Fatp4-/-
SC
retina will help to better understand the role of FATP1 and FATP4 in the transport and
NU
activation of FA in the retina.
MA
FATP and retinal degeneration
The loss of fatp results in retinal degeneration and was first observed in a genetic screen for Drosophila PR degeneration [85]. The characterization of retinal degeneration by live
D
imaging revealed that fatp-/- PRs were gradually lost during adulthood [69,86]. From these
TE
results, the Drosophila fatp mutant retina was proposed as a new model of progressive late-
AC CE P
onset PR degeneration [69]. PR degeneration in fatp mutant is due to a defect in the trafficking or degradation of Rh1 [69]. As a result, toxic Rh1-Arrestin2 complexes accumulate leading to PR death. The mechanisms by which fatp regulates Rh1 levels are not clear but this could be due to the regulation of phosphatidic acid or ceramide, which are important for Rh1 trafficking and/or degradation [87–89]. The regulation of Rh1 trafficking by fatp was confirmed in late pupal stage, in which fatp is regulated by RIDD and inhibits Rh1 delivery to the rhabdomere of the PR [78]. Thus, fatp is an essential gene for proper regulation of Rh1 and PR viability during terminal differentiation of PR and adulthood. Interestingly, a vital role has recently been observed for Fatp1 and Fatp4 in mouse retina models [70,82]. Fatp1 and Fatp4 are the two members of the FATP family expressed in the mouse retina, and they are the two members that share the closest homology with Drosophila fatp gene. Young Fatp1-/- mice have no evident ocular defect, but older Fatp1-/mice show signs of Aged-related Macular Degeneration (AMD) with PR outer segment disorganization, laminar thickening of the brush membrane and modified choroidal vessels
15
ACCEPTED MANUSCRIPT [70]. Although Fatp4-/- mice are embryonic lethal, study of Fatp4-/- retina has been performed in Fatp4-/- mice rescued by a keratinocyte-specific Fatp4 expression [82]. The keratinocyterescued Fatp4-/- mouse also exhibits retinal defects with a high light sensitivity. Light
PT
exposure for 1.5 h at 10,000 lux induces severe retinal degeneration with a decrease in the
RI
thickness of the upper outer nuclear layer and a decrease in Rhodopsin and M- and S-opsin levels due to the loss of rods and cones [82]. In the Fatp4-/- mouse model, light–induced
SC
degeneration correlates with the accumulation of the toxic all-trans retinal, the chromophore
NU
of Rhodopsin, released after Rhodopsin activation by light [82]. This results from the release of the inhibitory activity of FATP4 on the visual cycle (see the section below on the visual
MA
cycle for details). All together, these results indicate that the Fatp1 and Fatp4 genes are required for correct retinal function and survival. Construction of a double Fatp1-/- Fatp4-/- KO mouse will be necessary to determine a possible redundancy of the two proteins.
D
The loss of FATP is associated with retinal degeneration in both the Drosophila and mouse
AC CE P
evolution.
TE
models, indicating that the role of FATP in retinal physiology has been conserved throughout
Role of FATP proteins in the visual cycle The visual cycle regenerates the chromophore of Rhodopsin, the light-sensing part of the protein, after its activation (Fig. 3). Studies in mammals have revealed that FATP proteins play an important role in the RPE, in interactions with the key enzymes of the visual cycle (Fig. 3). Mouse FATP1 was initially identified as an RPE65-interacting protein in a yeast two-hybrid screen [81]. RPE65 is a key enzyme that isomerizes all-trans retinyl esters (atRE) to 11-cisretinol (11cROL) [90–92], which constitutes the rate-limiting step of the visual cycle [93]. FATP1 also physically interacts with the lecithin retinol acetyl transferase (LRAT), an enzyme catalyzing the production of all-trans retinyl ester in the RPE. Moreover, the authors of this study showed that FATP1 interacted functionally with RPE65 and LRAT, thereby inhibiting the production of 11-cis-retinol in vitro, which suggests that FATP1 is an inhibitor of the visual
16
ACCEPTED MANUSCRIPT cycle [81]. However, no defect in chromophore regeneration could be detected in vivo in Fatp1-/- mice, although these mice display early signs of AMD with aging [70]. As with retinal survival (see above), the absence of a visual cycle phenotype in vivo may reflect functional
PT
redundancy of FATP1 and FATP4 for chromophore regeneration. Consistent with this
RI
possibility, FATP4 has also been identified as a negative regulator of RPE65 [82]. In vitro enzymatic analyses showed that FATP4 inhibits RPE65 activity by competing for the same
SC
substrate and the product of FATP4 competes with atRE for the hydrophobic pocket of
NU
RPE65. In vivo, the FATP4-deficient RPE has significantly higher levels of isomerase activity, the key activity of the visual cycle catalyzed by RPE65. Moreover, FATP4-deficient mice
MA
display particularly high levels of the cytotoxic all-trans retinal, and this is probably responsible for the light-induced PR degeneration seen in these mice. Thus, both FATP1 and FATP4 are negative regulators of the visual cycle in mammals. Interestingly, LRAT and
TE
D
RPE65 catalyze two steps of the visual cycle during which the chromophore is bound to a FA, suggesting that the ACS or transporter activity of FATP1/4 may be involved.
AC CE P
By contrast, the role of Drosophila Fatp in the visual cycle remains to be explored. The visual cycle was discovered recently in Drosophila, with the identification of two retinol dehydrogenases:
the
pigment-cell-enriched
dehydrogenase
(PDH)
and
retinol
dehydrogenase B (RDHB) (Fig. 3) [94,95]. Studying the role of Fatp in the visual cycle in Drosophila would undoubtedly be informative. If Drosophila Fatp behaves as a negative regulator of the visual cycle, as in mammals, then chromophore availability should be higher in the fatp-/- retina and promote Rh1 synthesis as previously described [96]. This would account for the reported accumulation of Rh1 in the degenerating retina in flies [69]. The fly retina would then serve as a powerful model for future studies uncovering further genetic interactions with fatp in this process.
Role of FATP in fat storage TAG storage is confined to the evolutionarily conserved compartments termed lipid droplets (LDs) in specialized cells like the adipocytes in mammals, cells of the fat body in Drosophila
17
ACCEPTED MANUSCRIPT and intestinal cells of nematodes (Table1). TAG may also be stored, to a lesser extent, in other cell types such as the heart; however, accumulation of lipid droplets in the myocardium can become pathologic. TAG storage depends on cellular FA uptake, TAG synthesis and
RI
processes directly or indirectly in species from worm to human.
PT
TAG catabolism, and as presented in detail below, FATP proteins are involved in all three
The role of FATP in TAG storage as a result of the regulation of cellular FA uptake is well
SC
shown for FATP1 in mammals. FATP1 is expressed in white and brown adipose tissue, and
NU
in skeletal and cardiac muscle and increases fatty acid uptake. It responds to insulin by translocating from an intracellular perinuclear compartment to the plasma membrane and
MA
mediates insulin-stimulated FA cellular uptake [27,97]. Loss of Fatp1 in mice reduces coldinduced FA uptake and the size of the LDs in brown adipose tissue, which results in defects in non-shivering thermogenesis [98]. Loss of Fatp1 also protects mice from diet-induced
TE
D
obesity and insulin desensitization, by reducing insulin-stimulated uptake of fatty acids into muscle tissue and adipocytes, suggesting that molecules of the Fatp family could be effective
AC CE P
anti-diabetic targets [99]. In mice knocked out for Fatp5, specifically expressed in the basal membranes of hepatocytes , long-chain fatty acid uptake is reduced in hepatocytes, but not in muscle or adipose tissue [100]. These mice also fail to gain weight on a HFD because of both decreased food intake and increased energy expenditure [101]. Excitingly, induced knockdown of Fatp5 in the liver can reverse already established diet-induced hepatic steatosis in mice [100]. Thus, in mammals FATP1 and FATP5 promote TAG storage by increasing FA uptake and therefore are promising therapeutic candidates for obesity, diabetes and non-alcoholic fatty liver disease. In C.elegans, ACS-22 is part of a TAG synthesis complex that facilitates LD expansion. It was identified in a genetic suppressor screen of LD expansion in a daf-22 mutant background; in this background FA β-oxidation is disrupted in the peroxisome resulting in LD expansion [102]. ACS-22 on the endoplasmic reticulum (ER) membrane interacts physically and functionally with the diacylglycerol acyltransferase-2 (DGAT-2) on LD, an enzyme that catalyzes the conjugation of a fatty acyl-CoA to diacyl glycerol and generates TAG. This
18
ACCEPTED MANUSCRIPT interaction is conserved in mammalian cells, where FATP1 interacts with DGAT-2 [102]. Thus, thanks to the C.elegans model, it has been shown that in addition to increasing FA uptake, FATP1 promotes TAG storage as a component of the complex that enables ER–LD
PT
interaction and couples the synthesis of TAG and its deposition into LDs.
RI
In Drosophila, loss of one of the two copies of fatp results in increased TAG storage [68], which is in apparent contradiction with the role of FATP1, FATP5 and ACS-22 described
SC
above. In support of the Drosophila result, Fatp4A-/- mice, with adipocyte-specific inactivation
NU
of the Fatp4 gene, are obese when fed a high-fat diet whereas controls with identical food consumption are not [103]. In addition, increased incorporation of FA into TAG has also been
MA
reported in Fatp4 mutant fibroblasts in vitro [104]; decreased incorporation of FA into acylCoA but not into TAG has been described in Fatp4 mutant adipocytes in vitro [25]; and enterocytes from a Fatp4-null mouse with a rescued skin phenotype and fed a Western diet
TE
D
exhibit increased TAG content [105].
In all these situations, what could be the origin of the increased TAG storage? An increase in
AC CE P
FA uptake, an excessive trafficking of FA toward TAG, or a decrease in TAG lipolysis? It has been shown in the Fatp4A-/- mice that the higher TAG content in adipocytes does not result from a deregulation of FA uptake [103]. In the thicker subcutaneous adipose tissue, lipolysis enzymes are not affected but the lipid composition is: the abundance of complex lipids, such as phospholipids, sphingolipids and cholesterol ester, is reduced, suggesting that in the absence of FATP4 ACS activity at the ER, FA are not incorporated into these complex lipids but are channeled to other compartments in the ER to be incorporated into TAG [103]. This altered FA trafficking would be the reason of the increased TAG storage in the subcutaneous adipose tissue. In the visceral adipose tissue, the role of FATP4 seems different because the expression of the lipolysis enzymes is downregulated and the composition of complex lipids is not affected. In these cells, FATP4 may re-esterify FA originating from basal lipolysis [25]. In the absence of FATP4, the expression of lipolysis enzymes may be reduced such that potentially harmful nonesterified FA does not accumulate [103]. Reduction of lipolysis would result in increased
19
ACCEPTED MANUSCRIPT TAG storage. In support of this hypothesis, in Drosophila, fatp belongs to a group of genes involved in lipid catabolism and beta-oxidation that are expressed under starvation under the control of the conserved transcription factor dHNF4 [106]. It would be interesting to
PT
determine if mammalian FATPs also belong to such a gene network.
RI
The high TAG content in heterozygous fatp mutant flies is accompanied by a low feeding rate [68]. This is reminiscent of the reduced food intake by Fatp5 mutant mice on a HFD and
SC
suggests conservation of dietary behavior between Drosophila and mammals [101].
NU
Heterozygous fatp mutant flies also exhibit increased lifespan, independent of dietary nutrient content with no reduction in spontaneous activity or capacity for enforced exercise [68].
MA
Interestingly, knockdown of fatp expression in the fly fat body, which plays roles in the fly analogous to both vertebrate adipocytes and vertebrate liver is also sufficient to increase TAG storage, extend lifespan/stress resistance and reduce the feeding rate. This
TE
D
combination of phenotypes is reminiscent of hepatocyte-specific knockdown of Fatp5 in the mouse liver [107], suggesting a conserved link between Fatp family activity in liver-type
AC CE P
tissues and feeding rate/TAG storage. In summary, loss of fatp in Drosophila results in physiological phenotypes also observed in mammalian FATP knockdowns.
Role of FATP in the mammal skin and worm cuticle
The Ichthyosis Prematurity Syndrome (IPS) is a rare disease characterized by a defective barrier function of the skin and belongs to a heterogeneous group of keratinization disorders, called autosomal-recessive congenital ichthyosis (ARCI) [108,109]. In humans, the Fatp4 gene maps in the locus associated with IPS on chromosomes 9q33.3-q34.13. Nonsense and missense mutations in the human Fatp4 genes have been identified in patients with IPS, mostly in Scandinavian populations [9,10]. This is the first known example of a human inherited disease caused by deficiency of a FATP family member. Similarly to the human syndrome, mice invalidated for Fatp4 are affected by a skin disease. Spontaneous Fatp4 mutant mice, the wrinkle-free mice and the pigskin mice, and targeted
20
ACCEPTED MANUSCRIPT Fatp4-/- knockout mice all display a very tight, thick, wrinkle-free, shiny and smooth skin, with reduced numbers of hair follicles and a defective permeability barrier that no longer prevents loss of water from within [110–112]. They die neonatally due to dehydration and restricted
PT
movement. Fatp4-/- mice are rescued by the overexpression of Fatp4 specifically in epidermal
RI
keratinocytes, indicating a tissue-specific requirement for Fatp4 in the epidermis [113]. Transgene-rescued Fatp4 null mice exhibit abnormal development of sebaceous glands and
SC
abnormal sebum composition, implicating FATP4 in the formation of the sebaceous gland
NU
and sebum [114].
The lipid composition of Fatp4 mutant skin is highly abnormal with only low concentrations of
MA
ceramides containing VLCFA, which are crucial for normal barrier integrity [115], although the total amount of ceramide is higher than normal [111,113]. This paucity of VLCFAcontaining ceramides is possibly a direct consequence of the absence of the ACS activity of mutant
skin
are
D
Fatp4
also
characterized
by
a
defect
in
the
TE
FATP4.
proliferation/differentiation of the epidermis, with an abnormal thickness of the skin, due to an
AC CE P
increased number of proliferating cells in the suprabasal layer of the epidermis [112,116], with an altered expression profile of keratins [110,112] and with an abnormal activation of the EGF receptor and the downstream STAT3 signaling pathways [116]. In C. elegans, loss of acs-20 alone or loss of acs-20 and acs-22 results in a mild or severe disruption of the barrier function of the cuticle [46]. The structure of the acs-20;acs-22 mutant worm cuticle is abnormal. Tree longitudinal ridges on the cuticule on the lateral sides of the body, the alae, are incompletely extended, with a collagen-like matrix accumulation underneath and the accumulation of an unidentified matrix in the cuticle layers [46]. This is consistent with the phenotypes of Fatp4 mutant mice. Such a similar phenotype between mouse and worm is surprising as the structure of the worm cuticle is very different from that of the mammalian skin. Furthermore, acs-20 and acs-20;acs-22 mutant worms can be rescued by expressing a human Fatp4 transgene [46], suggesting that the role of FATP4 in the epidermis is fundamental and conserved from worm to humans. A detailed comparison
21
ACCEPTED MANUSCRIPT between the common features of worm cuticule and mammalian skin would be fruitful to better understand the role of FATP4 in the skin. Consistent with Fatp4 homologs having a role in the synthesis of lipids essential for the
PT
surface barrier, the incorporation of VLCFA into sphingomyelin is reduced in acs-20;acs-22
be
detected
at
the
level
of
epidermal
cells
RI
mutant animals [46]. However, no obvious defects in terms of cell fate or cell integrity could [46],
contrasting
with
the
SC
proliferation/differentiation defects in Fatp4 mutant mouse skin. This may be due to the
NU
different organization of nematode and mammalian epidermis, or it may reflect differences in the role of Fatp4 in epidermal proliferation/differentiation between species. Alternatively, the
MA
hyperproliferation of the mouse epidermis in Fatp4 mutant may be simply a response to loss of the permeability barrier function. In support of this hypothesis, the abnormal accumulation of matrix in acs-20 mutant worms may similarly compensate for the impaired lipid barrier [46].
TE
D
In Drosophila, loss of fatp is lethal at the transition between the first and second larval instar [69]. The cause of lethality has not been investigated and may involve cuticle defects, or
AC CE P
other defects affecting, for example, lipid absorption or lipid metabolism. This lethal phenotype is an ideal model to perform a mutagenesis suppressor screen and identify functional partners of fatp.
Conclusions and future outlook
In conclusion, development of invertebrate models to study FATP functions has revealed unexpected and underestimated parallels between vertebrate and invertebrate FATPs (Table3), the most surprising being at the level of the feeding rate behavior and at the level of the skin/cuticle as detailed above. In addition, it has enabled the characterization of new roles of FATPs in retinal cell survival and function, and in the synthesis and deposition of TAG in LDs. Some properties identified in invertebrate models, such as the regulation of fatp mRNA by ER stress, still need to be studied in vertebrate models.
22
ACCEPTED MANUSCRIPT The establishment of invertebrate models to study FATP now allows the use of the powerful genetics tools available in these models. In particular, unbiased genetic screening with genome-wide collections of mutants and knockdown lines and epistasis analyses will
PT
facilitate understanding the specific molecular interactions, the complex metabolic networks
RI
and the tissue-specific functions of FATPs in an in vivo, physiologically relevant context. A clear illustration is the identification of the FATP1-DGAT2 complex and its role in LD
SC
formation in C. elegans as described above. Lastly, these simple organisms are amenable to
NU
chemical testing and screening, and should be a powerful tool for inexpensive, in vivo testing of drugs for the treatment of lipid metabolic diseases. Altogether, the use of the invertebrate
AC CE P
TE
D
MA
models should contribute to a broad understanding of the FATP family.
23
ACCEPTED MANUSCRIPT Figure legends
Fig. 1: Transport and ACS activities of FATP proteins. These proteins promote the uptake of
PT
free FA by the cell and catalyse their esterification with CoA to generate acyl-CoA. In yeast, Fat1p makes a complex with the ACSL Faa1p and Faa4p to couple FA transport with
RI
activation, a process called vectorial acylation. FATP proteins are localized in the plasma
SC
membrane and in the membrane of internal organel such as the endoplasmic reticulum. FATP1 and FATP4 proteins translocate from intracellular compartment to the plasma
NU
membrane upon insulin-induced stimulation of the cell or muscle contraction.
MA
Fig. 2: Protein sequence conservation between Drosophila Fatp, human FATP1, 4 and 6, worm ACS-20 and ACS-22, and yeast Fat1p. The alignment was done with the MultAlin tool
D
[117] based on sequence similarity. Residues in red and blue correspond to residues for
TE
which there is a strong consensus (>90%) and a weak consensus (>50%), respectively. For the consensus sequence: ! is used for a I or V residue, $ for a L or M residue, % for a F or Y
AC CE P
residue and # for a N, D, Q or E residue. The magenta bars indicate the five consensus sequences for human acyl-coenzyme A synthetase (ACS) motifs, motif I and II correspond respectively to the ATP-AMP and FATP-ACSVL motifs [19]. Although originally proposed as a fatty acid-binding “signature motif” promoting acyl chain length specificity [118], examination of the crystal structure of Thermus thermophilus long-chain ACS suggests that Motif II may not be involved in chain length recognition [119,120]. Motif IV comprises the first five residues of the gate motif of Thermus thermophilus ACS (226-VPMFHVNAW-234), which controls the access of the fatty acid substrate to the catalytic site [119]. In the gate motif, the indole ring of W234 acts as the gate. This residue is not conserved in human ACS. Instead, a Y or F residue upstream of the motif IV has been proposed to play the role in ACSL6 [121,122]. Of note, in FATPs, a conserved aromatic residue (Y or F) is located 3 amino acid upstream of the motif IV. The blue stars denote the site required for yeast Fat1p activity [33]. The light blue stars label residues at which mutations distinguish between the
24
ACCEPTED MANUSCRIPT LCFA transport activity and the VLCFA ACS activity of Fat1p. The green bar indicates the position of the 73-amino acid segment of Fatp1 and 4 which is also important for their fatty
Fig. 3: Role of FATP in mouse and Drosophila retina
RI
PT
acid transport activity in fat1∆ faa1∆ yeast [47].
SC
In mouse (A), the visual cycle recycles the chromophore, 11-cis retinal, of Rh, the light-
NU
sensitive protein of PRs [for a review, see [123][124]]. Enzymes of this cycle are distributed over PRs and RPE. FATP1 has been shown to interact with and to inhibit two of these
MA
enzymes, LRAT and RPE65 [81]. FATP4 has been shown to inhibit the activity of RPE65 [82]. RPE65 is the isomerase and the rate-limiting enzyme of the cycle.
D
In Drosophila (B), Fatp is also expressed in PRs and pigment cells and is required for PR
TE
survival through Rh1 regulation [69]. The chromophore of Rh1 is a molecule of 3-hydroxyretinal (OHRal). The visual cycle in flies is not well documented: only two enzymes, PDH and
AC CE P
RDHB, involved in this cycle have been described and not all the retinoid intermediates have been identified [94,95]. 11c-Ral: 11-cis retinal, at-Ral: all-trans retinal, at-Rol: all-trans retinol, PE: phosphatidyl ethanolamine, N-ret-PE: N-retinylidene-PE, RDH: retinol dehydrogenase, LRAT: lecithin-retinol acetyl transferase
25
ACCEPTED MANUSCRIPT
Acknowledgments BM’s research was supported by grants from the Fondation pour la Recherche Médicale, the
PT
CNRS (ATIP) and the ANR-12-BSV1-0019-01. PD was supported by the Retina France
RI
Association and the Ecole Normale Supérieure of Lyon (France). AS and RW are supported by grants from the MPOB and the Physiology Department of the Wayne State University
NU
SC
School of Medicine.
Competing interest disclosure
AC CE P
TE
D
MA
The authors have no financial or competing interests to declare.
26
ACCEPTED MANUSCRIPT References Baker KD, Thummel CS. Diabetic larvae and obese flies-emerging studies of metabolism in Drosophila. Cell Metab 2007;6:257–66.
[2]
Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab 2010;21:345–52.
[3]
Bourre JM, Bonneil M, Chaudière J, Clément M, Dumont O, Durand G, et al. Structural and functional importance of dietary polyunsaturated fatty acids in the nervous system. Adv Exp Med Biol 1992;318:211–29.
[4]
Anderson CM, Stahl A. SLC27 fatty acid transport proteins. Mol Aspects Med 34:516– 28.
[5]
Kazantzis M, Stahl A. Fatty acid transport proteins, implications in physiology and disease. Biochim Biophys Acta 2012;1821:852–7.
[6]
Meirhaeghe A, Martin G, Nemoto M, Deeb S, Cottel D, Auwerx J, et al. Intronic polymorphism in the fatty acid transport protein 1 gene is associated with increased plasma triglyceride levels in a French population. Arterioscler Thromb Vasc Biol 2000;20:1330–4.
[7]
Gertow K, Skoglund-Andersson C, Eriksson P, Boquist S, Orth-Gomér K, SchenckGustafsson K, et al. A common polymorphism in the fatty acid transport protein-1 gene associated with elevated post-prandial lipaemia and alterations in LDL particle size distribution. Atherosclerosis 2003;167:265–73.
[8]
Gertow K, Bellanda M, Eriksson P, Boquist S, Hamsten A, Sunnerhagen M, et al. Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome. J Clin Endocrinol Metab 2004;89:392–9.
[9]
Klar J, Schweiger M, Zimmerman R, Zechner R, Li H, Törmä H, et al. Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome. Am J Hum Genet 2009;85:248–53.
[10]
Sobol M, Dahl N, Klar J. FATP4 missense and nonsense mutations cause similar features in Ichthyosis Prematurity Syndrome. BMC Res Notes 2011;4:90.
[11]
Auinger A, Valenti L, Pfeuffer M, Helwig U, Herrmann J, Fracanzani AL, et al. A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis. Horm Metab Res 2010;42:854–9.
[12]
Guillou H, Zadravec D, Martin PGP, Jacobsson A. The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res 2010;49:186–99.
[13]
Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev 31:134–78.
AC CE P
TE
D
MA
NU
SC
RI
PT
[1]
27
ACCEPTED MANUSCRIPT Schwudke D, Hannich JT, Surendranath V, Grimard V, Moehring T, Burton L, et al. Top-down lipidomic screens by multivariate analysis of high-resolution survey mass spectra. Anal Chem 2007;79:4083–93.
[15]
Carvalho M, Sampaio JL, Palm W, Brankatschk M, Eaton S, Shevchenko A. Effects of diet and development on the Drosophila lipidome. Mol Syst Biol 2012;8:600.
[16]
Liu Z, Huang X. Lipid metabolism in Drosophila: development and disease. Acta Biochim Biophys Sin (Shanghai) 2013;45:44–50.
[17]
Leopold P, Perrimon N. Drosophila and the genetics of the internal milieu. Nature 2007;450:186–8.
[18]
Zheng J, Greenway FL. Caenorhabditis elegans as a model for obesity research. Int J Obes (Lond) 2012;36:186–94.
[19]
Watkins PA, Maiguel D, Jia Z, Pevsner J. Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J Lipid Res 2007;48:2736–50.
[20]
Mishima T, Miner JH, Morizane M, Stahl A, Sadovsky Y. The expression and function of fatty acid transport protein-2 and -4 in the murine placenta. PLoS One 2011;6:e25865.
[21]
Gallardo D, Amills M, Quintanilla R, Pena RN. Mapping and tissue mRNA expression analysis of the pig solute carrier 27A (SLC27A) multigene family. Gene 2013;515:220– 3.
[22]
Black PN, DiRusso CC. Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification. Microbiol Mol Biol Rev 2003;67:454–72, table of contents.
[23]
Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994;79:427–36.
[24]
Coe NR, Smith AJ, Frohnert BI, Watkins PA, Bernlohr DA. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem 1999;274:36300–4.
[25]
Lobo S, Wiczer BM, Smith AJ, Hall AM, Bernlohr DA. Fatty acid metabolism in adipocytes: functional analysis of fatty acid transport proteins 1 and 4. J Lipid Res 2007;48:609–20.
[26]
Milger K, Herrmann T, Becker C, Gotthardt D, Zickwolf J, Ehehalt R, et al. Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4. J Cell Sci 2006;119:4678–88.
[27]
Stahl A, Evans JG, Pattel S, Hirsch D, Lodish HF. Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev Cell 2002;2:477–88.
[28]
Stahl A, Hirsch DJ, Gimeno RE, Punreddy S, Ge P, Watson N, et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 1999;4:299–308.
AC CE P
TE
D
MA
NU
SC
RI
PT
[14]
28
ACCEPTED MANUSCRIPT Faergeman NJ, DiRusso CC, Elberger A, Knudsen J, Black PN. Disruption of the Saccharomyces cerevisiae homologue to the murine fatty acid transport protein impairs uptake and growth on long-chain fatty acids. J Biol Chem 1997;272:8531–8.
[30]
Dirusso CC, Connell EJ, Faergeman NJ, Knudsen J, Hansen JK, Black PN. Murine FATP alleviates growth and biochemical deficiencies of yeast fat1Delta strains. Eur J Biochem 2000;267:4422–33.
[31]
Choi JY, Martin CE. The Saccharomyces cerevisiae FAT1 gene encodes an acyl-CoA synthetase that is required for maintenance of very long chain fatty acid levels. J Biol Chem 1999;274:4671–83.
[32]
Watkins PA, Lu JF, Steinberg SJ, Gould SJ, Smith KD, Braiterman LT. Disruption of the Saccharomyces cerevisiae FAT1 gene decreases very long-chain fatty acyl-CoA synthetase activity and elevates intracellular very long-chain fatty acid concentrations. J Biol Chem 1998;273:18210–9.
[33]
Zou Z, DiRusso CC, Ctrnacta V, Black PN. Fatty acid transport in Saccharomyces cerevisiae. Directed mutagenesis of FAT1 distinguishes the biochemical activities associated with Fat1p. J Biol Chem 2002;277:31062–71.
[34]
Zou Z, Tong F, Faergeman NJ, Børsting C, Black PN, DiRusso CC. Vectorial acylation in Saccharomyces cerevisiae. Fat1p and fatty acyl-CoA synthetase are interacting components of a fatty acid import complex. J Biol Chem 2003;278:16414–22.
[35]
Black PN, DiRusso CC. Vectorial acylation: linking fatty acid transport and activation to metabolic trafficking. Novartis Found Symp 2007;286:127–38; discussion 138–41, 162–3, 196–203.
[36]
DiRusso CC, Li H, Darwis D, Watkins PA, Berger J, Black PN. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J Biol Chem 2005;280:16829–37.
[37]
Melton EM, Cerny RL, Watkins PA, DiRusso CC, Black PN. Human fatty acid transport protein 2a/very long chain acyl-CoA synthetase 1 (FATP2a/Acsvl1) has a preference in mediating the channeling of exogenous n-3 fatty acids into phosphatidylinositol. J Biol Chem 2011;286:30670–9.
[38]
Steinberg SJ, Mihalik SJ, Kim DG, Cuebas DA, Watkins PA. The human liver-specific homolog of very long-chain acyl-CoA synthetase is cholate:CoA ligase. J Biol Chem 2000;275:15605–8.
[39]
Mihalik SJ, Steinberg SJ, Pei Z, Park J, Kim DG, Heinzer AK, et al. Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling. J Biol Chem 2002;277:24771–9.
[40]
Gimeno RE, Ortegon AM, Patel S, Punreddy S, Ge P, Sun Y, et al. Characterization of a heart-specific fatty acid transport protein. J Biol Chem 2003;278:16039–44.
[41]
Gargiulo CE, Stuhlsatz-Krouper SM, Schaffer JE. Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. J Lipid Res 1999;40:881–92.
AC CE P
TE
D
MA
NU
SC
RI
PT
[29]
29
ACCEPTED MANUSCRIPT Richards MR, Harp JD, Ory DS, Schaffer JE. Fatty acid transport protein 1 and longchain acyl coenzyme A synthetase 1 interact in adipocytes. J Lipid Res 2006;47:665– 72.
[43]
Krammer J, Digel M, Ehehalt F, Stremmel W, Füllekrug J, Ehehalt R. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells. Int J Med Sci 2011;8:599–614.
[44]
Zhan T, Poppelreuther M, Ehehalt R, Füllekrug J. Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 increase the cellular fatty acid uptake of 3T3-L1 adipocytes but are localized on intracellular membranes. PLoS One 2012;7:e45087.
[45]
Melton EM, Cerny RL, DiRusso CC, Black PN. Overexpression of human fatty acid transport protein 2/very long chain acyl-CoA synthetase 1 (FATP2/Acsvl1) reveals distinct patterns of trafficking of exogenous fatty acids. Biochem Biophys Res Commun 2013;440:743–8.
[46]
Kage-Nakadai E, Kobuna H, Kimura M, Gengyo-Ando K, Inoue T, Arai H, et al. Two very long chain fatty acid acyl-CoA synthetase genes, acs-20 and acs-22, have roles in the cuticle surface barrier in Caenorhabditis elegans. PLoS One 2010;5:e8857.
[47]
DiRusso CC, Darwis D, Obermeyer T, Black PN. Functional domains of the fatty acid transport proteins: studies using protein chimeras. Biochim Biophys Acta 2008;1781:135–43.
[48]
Ohnishi A, Hashimoto K, Imai K, Matsumoto S. Functional characterization of the Bombyx mori fatty acid transport protein (BmFATP) within the silkmoth pheromone gland. J Biol Chem 2009;284:5128–36.
[49]
Qian S, Fujii T, Ito K, Nakano R, Ishikawa Y. Cloning and functional characterization of a fatty acid transport protein (FATP) from the pheromone gland of a lichen moth, Eilema japonica, which secretes an alkenyl sex pheromone. Insect Biochem Mol Biol 2011;41:22–8.
[50]
Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994;1213:263–76.
[51]
Hauton D, Bennett MJ, Evans RD. Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference. Biochim Biophys Acta 2001;1533:99–109.
[52]
Niu Y-G, Hauton D, Evans RD. Utilization of triacylglycerol-rich lipoproteins by the working rat heart: routes of uptake and metabolic fates. J Physiol 2004;558:225–37.
[53]
Van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res 2000;45:279–93.
[54]
Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999;274:19055–62.
AC CE P
TE
D
MA
NU
SC
RI
PT
[42]
30
ACCEPTED MANUSCRIPT Herrmann T, Buchkremer F, Gosch I, Hall AM, Bernlohr DA, Stremmel W. Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene 2001;270:31–40.
[56]
Sorrentino D, Stump D, Potter BJ, Robinson RB, White R, Kiang CL, et al. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J Clin Invest 1988;82:928–35.
[57]
Heather LC, Cole MA, Lygate CA, Evans RD, Stuckey DJ, Murray AJ, et al. Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart. Cardiovasc Res 2006;72:430–7.
[58]
Chiu H-C, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005;96:225–33.
[59]
Bonen A, Luiken JJFP, Glatz JFC. Regulation of fatty acid transport and membrane transporters in health and disease. Mol Cell Biochem 2002;239:181–92.
[60]
Steinbusch LKM, Dirkx E, Hoebers NTH, Roelants V, Foretz M, Viollet B, et al. Overexpression of AMP-activated protein kinase or protein kinase D prevents lipidinduced insulin resistance in cardiomyocytes. J Mol Cell Cardiol 2013;55:165–73.
[61]
Piazza N, Wessells RJ. Drosophila models of cardiac disease. Prog Mol Biol Transl Sci 2011;100:155–210.
[62]
Birse RT, Choi J, Reardon K, Rodriguez J, Graham S, Diop S, et al. High-fat-dietinduced obesity and heart dysfunction are regulated by the TOR pathway in Drosophila. Cell Metab 2010;12:533–44.
[63]
Diop SB, Bodmer R. Drosophila as a model to study the genetic mechanisms of obesity-associated heart dysfunction. J Cell Mol Med 2012;16:966–71.
[64]
Na J, Musselman LP, Pendse J, Baranski TJ, Bodmer R, Ocorr K, et al. A Drosophila model of high sugar diet-induced cardiomyopathy. PLoS Genet 2013;9:e1003175.
[65]
Diop SB, Bisharat-Kernizan J, Birse RT, Oldham S, Ocorr K, Bodmer R. PGC1/Spargel Counteracts High-Fat-Diet-Induced Obesity and Cardiac Lipotoxicity Downstream of TOR and Brummer ATGL Lipase. Cell Rep 2015.
[66]
Bazzell B, Ginzberg S, Healy L, Wessells RJ. Dietary composition regulates Drosophila mobility and cardiac physiology. J Exp Biol 2013;216:859–68.
[67]
Gill S, Le HD, Melkani GC, Panda S. Time-restricted feeding attenuates age-related cardiac decline in Drosophila. Science (80- ) 2015;347:1265–9.
[68]
Sujkowski A, Saunders S, Tinkerhess M, Piazza N, Jennens J, Healy L, et al. dFatp regulates nutrient distribution and long-term physiology in Drosophila. Aging Cell 2012;11:921–32.
AC CE P
TE
D
MA
NU
SC
RI
PT
[55]
31
ACCEPTED MANUSCRIPT Dourlen P, Bertin B, Chatelain G, Robin M, Napoletano F, Roux MJ, et al. Drosophila fatty acid transport protein regulates rhodopsin-1 metabolism and is required for photoreceptor neuron survival. PLoS Genet 2012;8:e1002833.
[70]
Chekroud K, Guillou L, Grégoire S, Ducharme G, Brun E, Cazevieille C, et al. Fatp1 deficiency affects retinal light response and dark adaptation, and induces age-related alterations. PLoS One 2012;7:e50231.
[71]
Diomede L, Rognoni P, Lavatelli F, Romeo M, del Favero E, Cantù L, et al. A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis. Blood 2014;123:3543–52.
[72]
Ward A, Liu J, Feng Z, Xu XZS. Light-sensitive neurons and channels mediate phototaxis in C. elegans. Nat Neurosci 2008;11:916–22.
[73]
Cook T, Zelhof A, Mishra M, Nie J. 800 facets of retinal degeneration. Prog Mol Biol Transl Sci 2011;100:331–68.
[74]
Simó R, Villarroel M, Corraliza L, Hernández C, Garcia-Ramírez M. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010;2010:190724.
[75]
Bazan NG. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids 2009;81:205–11.
[76]
Hardie RC, Franze K. Photomechanical responses in Drosophila photoreceptors. Science 2012;338:260–3.
[77]
Mollereau B, Domingos PM. Photoreceptor differentiation in Drosophila: from immature neurons to functional photoreceptors. Dev Dyn 2005;232:585–92.
[78]
Coelho DS, Cairrão F, Zeng X, Pires E, Coelho A V, Ron D, et al. Xbp1-independent ire1 signaling is required for photoreceptor differentiation and rhabdomere morphogenesis in Drosophila. Cell Rep 2013;5:791–801.
[79]
Fu S, Watkins SM, Hotamisligil GS. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab 2012;15:623–34.
[80]
Hetz C, Mollereau B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 2014;15:233–49.
[81]
Guignard TJP, Jin M, Pequignot MO, Li S, Chassigneux Y, Chekroud K, et al. FATP1 inhibits 11-cis retinol formation via interaction with the visual cycle retinoid isomerase RPE65 and lecithin:retinol acyltransferase. J Biol Chem 2010;285:18759–68.
[82]
Li S, Lee J, Zhou Y, Gordon WC, Hill JM, Bazan NG, et al. Fatty acid transport protein 4 (FATP4) prevents light-induced degeneration of cone and rod photoreceptors by inhibiting RPE65 isomerase. J Neurosci 2013;33:3178–89.
AC CE P
TE
D
MA
NU
SC
RI
PT
[69]
32
ACCEPTED MANUSCRIPT Mitchell RW, Edmundson CL, Miller DW, Hatch GM. On the mechanism of oleate transport across human brain microvessel endothelial cells. J Neurochem 2009;110:1049–57.
[84]
Mitchell RW, On NH, Del Bigio MR, Miller DW, Hatch GM. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. J Neurochem 2011;117:735–46.
[85]
Gambis A, Dourlen P, Steller H, Mollereau B. Two-color in vivo imaging of photoreceptor apoptosis and development in Drosophila. Dev Biol 2011;351:128–34.
[86]
Dourlen P, Levet C, Mejat A, Gambis A, Mollereau B. The Tomato/GFP-FLP/FRT method for live imaging of mosaic adult Drosophila photoreceptor cells. J Vis Exp 2013:e50610.
[87]
Acharya U, Patel S, Koundakjian E, Nagashima K, Han X, Acharya JK. Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration. Science 2003;299:1740–3.
[88]
Acharya U, Mowen MB, Nagashima K, Acharya JK. Ceramidase expression facilitates membrane turnover and endocytosis of rhodopsin in photoreceptors. Proc Natl Acad Sci U S A 2004;101:1922–6.
[89]
Raghu P, Coessens E, Manifava M, Georgiev P, Pettitt T, Wood E, et al. Rhabdomere biogenesis in Drosophila photoreceptors is acutely sensitive to phosphatidic acid levels. J Cell Biol 2009;185:129–45.
[90]
Jin M, Li S, Moghrabi WN, Sun H, Travis GH. Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 2005;122:449–59.
[91]
Moiseyev G, Chen Y, Takahashi Y, Wu BX, Ma J-X. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci U S A 2005;102:12413–8.
[92]
Redmond TM, Poliakov E, Yu S, Tsai J-Y, Lu Z, Gentleman S. Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc Natl Acad Sci U S A 2005;102:13658–63.
[93]
Winston A, Rando RR. Regulation of isomerohydrolase activity in the visual cycle. Biochemistry 1998;37:2044–50.
[94]
Wang X, Wang T, Ni JD, von Lintig J, Montell C. The Drosophila visual cycle and de novo chromophore synthesis depends on rdhB. J Neurosci 2012;32:3485–91.
[95]
Wang X, Wang T, Jiao Y, von Lintig J, Montell C. Requirement for an enzymatic visual cycle in Drosophila. Curr Biol 2010;20:93–102.
[96]
Ozaki K, Nagatani H, Ozaki M, Tokunaga F. Maturation of major Drosophila rhodopsin, ninaE, requires chromophore 3-hydroxyretinal. Neuron 1993;10:1113–9.
[97]
Jain SS, Chabowski A, Snook LA, Schwenk RW, Glatz JFC, Luiken JJFP, et al. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett 2009;583:2294–300.
AC CE P
TE
D
MA
NU
SC
RI
PT
[83]
33
ACCEPTED MANUSCRIPT Wu Q, Kazantzis M, Doege H, Ortegon AM, Tsang B, Falcon A, et al. Fatty acid transport protein 1 is required for nonshivering thermogenesis in brown adipose tissue. Diabetes 2006;55:3229–37.
[99]
Wu Q, Ortegon AM, Tsang B, Doege H, Feingold KR, Stahl A. FATP1 is an insulinsensitive fatty acid transporter involved in diet-induced obesity. Mol Cell Biol 2006;26:3455–67.
PT
[98]
SC
RI
[100] Doege H, Baillie RA, Ortegon AM, Tsang B, Wu Q, Punreddy S, et al. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 2006;130:1245–58.
NU
[101] Hubbard B, Doege H, Punreddy S, Wu H, Huang X, Kaushik VK, et al. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity. Gastroenterology 2006;130:1259–69.
MA
[102] Xu N, Zhang SO, Cole RA, McKinney SA, Guo F, Haas JT, et al. The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface. J Cell Biol 2012;198:895–911.
D
[103] Lenz L-S, Marx J, Chamulitrat W, Kaiser I, Gröne H-J, Liebisch G, et al. Adipocytespecific inactivation of Acyl-CoA synthetase fatty acid transport protein 4 (Fatp4) in mice causes adipose hypertrophy and alterations in metabolism of complex lipids under high fat diet. J Biol Chem 2011;286:35578–87.
AC CE P
TE
[104] Jia Z, Pei Z, Maiguel D, Toomer CJ, Watkins PA. The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers? J Mol Neurosci 2007;33:25–31. [105] Shim J, Moulson CL, Newberry EP, Lin M-H, Xie Y, Kennedy SM, et al. Fatty acid transport protein 4 is dispensable for intestinal lipid absorption in mice. J Lipid Res 2009;50:491–500. [106] Palanker L, Tennessen JM, Lam G, Thummel CS. Drosophila HNF4 regulates lipid mobilization and beta-oxidation. Cell Metab 2009;9:228–39. [107] Doege H, Stahl A. Protein-mediated fatty acid uptake: novel insights from in vivo models. Physiology (Bethesda) 2006;21:259–68. [108] Klar J, Gedde-Dahl T, Larsson M, Pigg M, Carlsson B, Tentler D, et al. Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13. J Med Genet 2004;41:208–12. [109] Akiyama M, Shimizu H. An update on molecular aspects of the non-syndromic ichthyoses. Exp Dermatol 2008;17:373–82. [110] Moulson CL, Martin DR, Lugus JJ, Schaffer JE, Lind AC, Miner JH. Cloning of wrinklefree, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development. Proc Natl Acad Sci U S A 2003;100:5274–9.
34
ACCEPTED MANUSCRIPT [111] Herrmann T, van der Hoeven F, Grone H-J, Stewart AF, Langbein L, Kaiser I, et al. Mice with targeted disruption of the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene show features of lethal restrictive dermopathy. J Cell Biol 2003;161:1105–15.
PT
[112] Tao J, Koster MI, Harrison W, Moran JL, Beier DR, Roop DR, et al. A spontaneous Fatp4/Scl27a4 splice site mutation in a new murine model for congenital ichthyosis. PLoS One 2012;7:e50634.
SC
RI
[113] Moulson CL, Lin M-H, White JM, Newberry EP, Davidson NO, Miner JH. Keratinocytespecific expression of fatty acid transport protein 4 rescues the wrinkle-free phenotype in Slc27a4/Fatp4 mutant mice. J Biol Chem 2007;282:15912–20.
NU
[114] Lin M-H, Hsu F-F, Miner JH. Requirement of fatty acid transport protein 4 for development, maturation, and function of sebaceous glands in a mouse model of ichthyosis prematurity syndrome. J Biol Chem 2013;288:3964–76.
MA
[115] Feingold KR. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 2007;48:2531–46. [116] Lin M-H, Chang K-W, Lin S-C, Miner JH. Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signaling. Dev Biol 2010;344:707–19.
TE
D
[117] Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 1988;16:10881–90.
AC CE P
[118] Black PN, Zhang Q, Weimar JD, DiRusso CC. Mutational analysis of a fatty acylcoenzyme A synthetase signature motif identifies seven amino acid residues that modulate fatty acid substrate specificity. J Biol Chem 1997;272:4896–903. [119] Hisanaga Y, Ago H, Nakagawa N, Hamada K, Ida K, Yamamoto M, et al. Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer. J Biol Chem 2004;279:31717–26. [120] Watkins PA. Very-long-chain acyl-CoA synthetases. J Biol Chem 2008;283:1773–7. [121] Soupene E, Kuypers FA. Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol Biol 2006;7:21. [122] Soupene E, Dinh NP, Siliakus M, Kuypers FA. Activity of the acyl-CoA synthetase ACSL6 isoforms: role of the fatty acid Gate-domains. BMC Biochem 2010;11:18. [123] Molday RS, Zhang K. Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration. Prog Lipid Res 2010;49:476–92. [124] Kiser PD, Golczak M, Maeda A, Palczewski K. Key enzymes of the retinoid (visual) cycle in vertebrate retina. Biochim Biophys Acta 2012;1821:137–51. [125] Greenberg AS, Coleman RA. Expanding roles for lipid droplets. Trends Endocrinol Metab 2011;22:195–6.
35
ACCEPTED MANUSCRIPT [126] Gutierrez E, Wiggins D, Fielding B, Gould AP. Specialized hepatocyte-like cells regulate Drosophila lipid metabolism. Nature 2007;445:275–80. [127] Grönke S, Beller M, Fellert S, Ramakrishnan H, Jäckle H, Kühnlein RP. Control of fat storage by a Drosophila PAT domain protein. Curr Biol 2003;13:603–6.
PT
[128] Zhang SO, Trimble R, Guo F, Mak HY. Lipid droplets as ubiquitous fat storage organelles in C. elegans. BMC Cell Biol 2010;11:96.
SC
RI
[129] Rulifson EJ, Kim SK, Nusse R. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 2002;296:1118–20.
NU
[130] Bai H, Kang P, Tatar M. Drosophila insulin-like peptide-6 (dilp6) expression from fat body extends lifespan and represses secretion of Drosophila insulin-like peptide-2 from the brain. Aging Cell 2012;11:978–85.
MA
[131] Colombani J, Andersen DS, Léopold P. Secreted peptide Dilp8 coordinates Drosophila tissue growth with developmental timing. Science 2012;336:582–5. [132] Hermann GJ, Schroeder LK, Hieb CA, Kershner AM, Rabbitts BM, Fonarev P, et al. Genetic analysis of lysosomal trafficking in Caenorhabditis elegans. Mol Biol Cell 2005;16:3273–88.
TE
D
[133] O’Rourke EJ, Soukas AA, Carr CE, Ruvkun G. C. elegans major fats are stored in vesicles distinct from lysosome-related organelles. Cell Metab 2009;10:430–5.
AC CE P
[134] Leung B, Hermann GJ, Priess JR. Organogenesis of the Caenorhabditis elegans intestine. Dev Biol 1999;216:114–34. [135] Hellerer T, Axäng C, Brackmann C, Hillertz P, Pilon M, Enejder A. Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy. Proc Natl Acad Sci U S A 2007;104:14658–63. [136] Mak HY. Lipid droplets as fat storage organelles in Caenorhabditis elegans: Thematic Review Series: Lipid Droplet Synthesis and Metabolism: from Yeast to Man. J Lipid Res 2012;53:28–33. [137] Kühnlein RP. Thematic review series: Lipid droplet synthesis and metabolism: from yeast to man. Lipid droplet-based storage fat metabolism in Drosophila. J Lipid Res 2012;53:1430–6.
36
ACCEPTED MANUSCRIPT
AC CE P
TE
D
MA
NU
SC
RI
PT
Figure 1
37
ACCEPTED MANUSCRIPT
AC CE P
TE
D
MA
NU
SC
RI
PT
Figure 2
38
ACCEPTED MANUSCRIPT
AC CE P
TE
D
MA
NU
SC
RI
PT
Figure 3
39
ACCEPTED MANUSCRIPT Table 1: Conservation of cells and organs involved in lipid metabolism in mammals, nematodes and insects. Nematodes (C.elegans) 4µg
Oenocytes and cells of the fat body fulfill functions of liver hepatocytes including fat storage in lipid droplets and lipid mobilization [1,126,127].
Neutral lipids are stored in LRO and LD, localized in intestinal cells* [128].
Beta cells in the pancreas, secrete insulin which regulates lipid metabolism [2]
Eight Drosophila insulinlike peptides (DILPs) regulate lipid metabolism. DILPs synthesized by cells analogous to beta cells located in the brain and other tissues [129– 131].
No orthologous structure but insulin signaling regulates lipid mass in response to fasting and growth
SC
RI
PT
Liver (hepatocytes) Adipose tissue Fat storage in lipid droplets and lipid mobilization [125]
MA
Cells regulating carbohydrates and lipid metabolism
Insects (D. melanogaster) 0,5mg
NU
Animal approx. weight Organs dedicated to fat storage and metabolism
Mammals (M. musculus) 30g
AC CE P
TE
D
* There is still some debate about the nature of fatty acid storage organelles in C. elegans. They have been called gut granules, lysosome-related organelles (LRO) [132], vesicles distinct from LRO [133] and lipid droplets [134,135]. Using the selective staining properties of Nile Red (LRO only) and BODIPY (LRO and LD), Mak and col. were able to separate LD from LRO by centrifugation [128] and study the mechanisms regulating LD expansion [102,128]. These studies indicate that LD are fat storage structures conserved through evolution; they can be studied by applying the powerful genetic techniques available in C. elegans and Drosophila [136,137].
40
ACCEPTED MANUSCRIPT Table 2: Nomenclature and tissue expression of FATP genes in mouse, Drosophila and C. elegans. For the mouse genes, the nomenclature corresponds to the FATP nomenclature, the official nomenclature and the ACSVL nomenclature. FATP1 and FATP4 are in bold
RI
Superscript symbols show analogous organ between species.
NU
Fatp3/Slc27a3/Acsvl3 Fatp4/Slc27a4/Acsvl5
MA
Mouse
Fatp2/Slc27a2/Acsvl1
Fatp5/Slc27a5/Acsvl6
D
Fatp6/Slc27a6/Acsvl2
TE AC CE P
D.melanogaster
Tissue expression mainly in: heart !, muscle#, retina§, adipose tissue$, and in: brain%, kidney, liver, lung, colon¤, placenta, ovary, testis, pancreas, small intestine¤ mainly in: liver, kidney, small intestine¤ and in: lung, colon¤, placenta, ovary, testis, Kidney, lung, ovary, testis, adrenal gland, mainly in: heart !, muscle#, retina§, small intestine¤, skin, and in: brain%, kidney, liver, lung, colon¤, placenta, ovary, testis, adipose tissue$ Mainly in: liver and in: kidney, lung mainly in: lung, testis, placenta and in: liver, ovary,heart ! Adult -very strongly expressed in: retina§, hindgut¤, fat body$, heart !, carcass -highly expressed in: head, crop, midgut¤, male accessory gland -moderately expressed in: brain%, malpighian tubules, salivary gland, virgin female spermatheca, inseminated female spermatheca Larva: -highly expressed in: midgut¤ -moderately expressed in: central nervous system%, hindgut¤, malpighian tubules, fat body$, salivary gland, trachea, carcass Adult -moderately expressed in: midgut¤, malpighian tubules, fat body$, virgin female spermatheca, inseminated female spermatheca, ovary, testis Larva: -very strongly expressed in: malpighian tubules, fat body$ -highly expressed in: midgut¤ -moderately expressed in: hindgut¤
SC
Gene name Fatp1/Slc27a1/Acsvl4
fatp
CG3394
CG30194
PT
because they are more closely related to the Drosophila and C.elegans orthologs.
moderately expressed in: testis
41
head neuron% intestine¤ pharynx! hypodermis
NU
MA D TE AC CE P 42
RI
acs-22
SC
Intestine¤ hyp7 syncytium hypodermis* reproductive system pharynx! seam cell anal sphincter muscle# anal depressor muscle# vulval muscle# head
C.elegans
acs-20
PT
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT
AC CE P
TE
D
MA
NU
SC
RI
PT
Table3 : Main processes and associated human diseases in which FATP genes are involved in mammals, Drosophila and C.elegans. “X” means required in the process, “0” not required in the process or in the organ, “?” means that the role of FATP is unknown. Processes Associated human Mammals Drosophila C.elegans diseases fat storage Obesity, nonX X ? alcoholic fatty liver disease LD expansion X ? X Feeding rate X X ? Heart lipotoxicity cardiomyopathy X X 0 Electrophysiological X X ? activity Retinal Macular X X 0 degeneration degenerations Epidermis Ichthyosis X ? X development and Prematurity maintenance syndrome thermogenesis X 0 0 Resistance to ? X ? stress/longevity
43